CIK 0001728328 · <br>Emerging growth company
InMed Pharmaceuticals Inc.
Sign in to watch- Tickers
- INM MTRI
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Jun 30
- Incorporated
- British Columbia, Canada
- Entity type
- operating
- Phone
- (604) 669-7207
- Business address
- C/O NORTON ROSE FULBRIGHT CANADA LLP, SUITE 1800 - 510 WEST GEORGIA STREET, VANCOUVER, British Columbia, Canada, V6B 0M3
Securities
- INM Common stock Nasdaq
- MTRI Common Stock Nasdaq
- 4 Insider Changes in Ownership
- S-4/A Deal Registration Statement - Business Combination
- 425 Deal Prospectus/Communication re Business Combination
- 10-K Report Annual Report
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 425 Deal Prospectus/Communication re Business Combination
- 425 Deal Prospectus/Communication re Business Combination
- 8-K Event Regulation FD disclosure · Other events
- 425 Deal Prospectus/Communication re Business Combination
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 425 Deal Prospectus/Communication re Business Combination
- 8-K Event Material agreement · Regulation FD disclosure
- 4 Insider Changes in Ownership
- S-4 Deal Registration Statement - Business Combination
- SCHEDULE 13D Stake Beneficial Ownership Report
- 4 Insider Changes in Ownership
- 3 Insider Initial Statement of Ownership
- 8-K Event Other events
- SCHEDULE 13G Stake Statement of Beneficial Ownership
Page 2 of 26 · 517 filings